One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates
Paul W. Denton(University of Nebraska at Omaha), J. Víctor García(University of North Carolina at Chapel Hill), Florence A. Othieno(The University of Texas Southwestern Medical Center), Daniel A. Powell(University of Maryland, Baltimore), John F. Krisko(University of North Carolina at Chapel Hill), Brett D. Welch(University of Utah), Angela Wahl(University of North Carolina at Chapel Hill), Michael S. Kay(The Stables), Min Lu(Cornell University), Ettore Appella(National Institutes of Health), Philippe Gallay(Scripps Research Institute), Elisa H. Fleming(The University of Texas Southwestern Medical Center), Sima Zein(Southwestern Medical Center), Wei Zou(Nanchang University), Youn Tae Kwak(The University of Texas Southwestern Medical Center), Deborah Payne(Auckland University of Technology), Francisco Martinez-Torres(University of North Carolina at Chapel Hill), Jacob D. Estes(Oregon National Primate Research Center)
Cited by 137
Related Papers
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
|Science|1996|4.9k
DNA damage activates p53 through a phosphorylation–acetylation cascade
|Genes & Development|1998|1.2k
Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells
|Nature|2005|944
Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.
|Proceedings of the National Academy of Sciences|1979|732
HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
|Proceedings of the National Academy of Sciences|1997|483